West Pharmaceutical Services, Inc.: how funds voted at the meeting of 6 May 2025
- Ticker
- WST
- Meeting
- Season
- year to 30 June 2025
- Filers reporting
- 926
- Ballot items
- 6
926 filers on Form N-PX reported votes at the West Pharmaceutical Services, Inc. meeting of 6 May 2025. The records fall into 6 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of West Pharmaceutical Services, Inc. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2025. Filings read through . How the figures are made
The ballot
Item 1: Director elections
12 nominees. 96.9% of the reported votes are for. 49 filers withheld from or voted against at least one nominee.
8,005 vote records from 271 filers. 2 of the 270 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 52 fund families
- For 52
Item 2: Advisory vote on executive pay (say-on-pay)
1,512 vote records from 922 filers. 68 of the 900 filers that marked the item voted against management. 22 filers gave no management mark.
- Positions of 54 fund families
- For 52
- Against 2
- Against management 2
Item 3: Audit-related items (auditor ratification)
668 vote records from 271 filers. 7 of the 270 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 52 fund families
- For 52
Item 4: SHAREHOLDER RIGHTS AND DEFENSES: management items
The company's items in this category are shown together, because filers word and number them differently.
134 vote records from 46 filers. 7 of the 46 filers that marked the item voted against management.
- Positions of 11 fund families
- For 10
- Against 1
- Against management 1
Item 5: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
690 vote records from 278 filers. 11 of the 278 filers that marked the item voted against management.
- Positions of 51 fund families
- For 50
- Against 1
- Against management 1
Item 6: CORPORATE GOVERNANCE: management items
The company's items in this category are shown together, because filers word and number them differently.
533 vote records from 231 filers. 2 of the 230 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 44 fund families
- For 44
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
Questions
- How many filers reported votes at the West Pharmaceutical Services, Inc. meeting?
- 926 Form N-PX filers reported votes at the meeting of 6 May 2025. On say-on-pay, 68 of 900 filers that marked the item voted against management (7.6%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. West Pharmaceutical Services, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list West Pharmaceutical Services, Inc. with a meeting date within three days of 6 May 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .